Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study

Authors: Hess, Georg, Dreyling, Martin, Oberic, Lucie, Gine, Eva, Zinzani, Pier Luigi, Linton, Kim, Vilmar, Adam, Jerkeman, Mats, Chen, Jenny M. H., Ohler, Anke, Stilgenbauer, Stephan, Thieblemont, Catherine, Lambert, Jonathan, Zilioli, Vittorio Ruggero, Sancho, Juan‐Manuel, Jiménez‐Ubieto, Ana, Fischer, Luca, Eyre, Toby A., Keeping, Sam, Park, Julie E., Wu, James J., Siddiqi, Rubina, Reitan, John, Wade, Sally, Salles, Gilles

Source: British journal of haematology. 202(4):749-759

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194155453.0x000001&indx=1&recIds=ETOCvdc_100194155453.0x000001

Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study

Authors: Vilmar, Adam, Dehlendorff, Christian, Friis, Søren, Jäättelä, Marja, Tvingsholm, Siri, Frederiksen, Henrik

Source: Leukemia & lymphoma. 64(8):1451-1457

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190064241.0x000001&indx=1&recIds=ETOCvdc_100190064241.0x000001

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

Authors: Hess, Georg, Dreyling, Martin, Oberic, Lucie, Gine, Eva, Zinzani, Pier Luigi, Linton, Kim, Vilmar, Adam, Jerkeman, Mats, Chen, Jenny M. H., Ohler, Anke, Stilgenbauer, Stephan, Thieblemont, Catherine, Lambert, Jonathan, Zilioli, Vittorio Ruggero, Sancho, Juan-Manuel, Jimenez-Ubieto, Ana, Fischer, Luca, Eyre, Toby A., Keeping, Sam, Park, Julie E.

Source: Leukemia & Lymphoma; Jan2024, Vol. 65 Issue 1, p14-25, 12p

Subject Terms: MANTLE cell lymphoma, BRUTON tyrosine kinase, PROTEIN-tyrosine kinase inhibitors, PROGNOSIS, OVERALL survival

A Comparison of Overall Survival with Brexucabtagene Autoleucel (Brexu-cel) CAR T-Cell Therapy (ZUMA-2) and Standard of Care (SCHOLAR-2) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (BTKi)

Authors: Hess, Georg ^*, Dreyling, Martin, Oberic, Lucie ^*, Gine, Eva, Zinzani, Pier Luigi, Linton, Kim M. ^*, Vilmar, Adam ^*, Jerkeman, Mats, Chen, Jenny MH ^*, Ohler, Anke ^*, Stilgenbauer, Stephan ^*, Thieblemont, Catherine, Lambert, Jonathan ^*, Zilioli, Vittorio Ruggero ^*, Sancho, Juan-Manuel ^*, Jimenez-Ubieto, Ana ^*, Fischer, Luca ^*, Eyre, Toby A. ^*, Keeping, Sam ^*, Park, Julie E ^*, Wu, James J ^*, Siddiqi, Rubina ^*, Reitan, John ^*, Castaigne, Gab ^*, Salles, Gilles

Source: In Blood 15 November 2022 140 Supplement 1:10296-10299

ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial

Authors: Vilmar, Adam, Santoni-Rugiu, Eric, Sørensen, Jens Benn

Source: In European Journal of Cancer 2010 46(9):1554-1562

An Updated Comparison of Overall Survival with Brexucabtagene Autoleucel (Brexu-cel) CAR T-Cell Therapy (ZUMA-2) Versus Standard of Care (SCHOLAR-2) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (BTKi)

Authors: Hess, Georg, Dreyling, Martin, Oberic, Lucie, Gine, Eva, Zinzani, Pier Luigi, Linton, Kim M, Vilmar, Adam, Jerkeman, Mats, Chen, Jenny M H, Ohler, Anke, Stilgenbauer, Stephan, Thieblemont, Catherine, Lambert, Jonathan, Zilioli, Vittorio Ruggero, Sancho, Juan-Manuel, Jimenez-Ubieto, Ana, Fischer, Luca, Eyre, Toby A, Keeping, Sam, Park, Julie E, Wu, James J, Nunes, Ana, Reitan, John, Wade, Sally W, Salles, Gilles

Source: In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S359-S360

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasi s on carboplatin: A review of current literature

Authors: Vilmar, Adam, Sørensen, Jens Benn

Source: In Lung Cancer 2009 64(2):131-139

87-årig kvinde påkørt af flugtbilist og helbredt for højmalignt lymfom

Authors: Vilmar, Adam Christian, Hansen, Boye

Source: Ugeskrift for læger. 178(25):2385-2385

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN609523345&indx=1&recIds=ETOCRN609523345

Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma

Authors: Vilmar, Adam ^*, Arboe, Bente ^*, Josefsson, Par, Poulsen, Christian ^*, Christensen, Jacob Haaber ^*, Jørgensen, Judit ^*, Jensen, Paw ^*, Starklint, Jørn ^*, Pedersen, Per Troellund ^*, Pedersen, Michael ^*, Brown, Peter de Nully

Source: In Blood 2 December 2016 128(22):1781-1781

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Adjuvant chemotherapy in elderly patients (>or=75 yr) completely resected for colon cancer stage III compared to younger patients: toxicity and prognosis.

Authors: Jensen, Søren, Vilmar, Adam, Sørensen, Jens, Jensen, Søren Astrup, Sørensen, Jens Benn

Source: Medical Oncology; Dec2006, Vol. 23 Issue 4, p521-531, 11p

Customizing Chemotherapy in Thoracic Malignancies based on ERCC1 Expression

Authors: S⊘rensen, Jens Benn, Jakobsen, Jan Nyrop, Zimling, Zarah, Wallerek, Sandra, Vilmar, Adam

Source: Lung Cancer Management; August 2013, Vol. 2 Issue: 4 p295-307, 13p

Adjuvant chemotherapy in elderly patients (≥75 yr) completely resected for colon cancer stage III compared to younger patients

Authors: Jensen, Søren, Vilmar, Adam, Sørensen, Jens

Source: Medical Oncology; December 2006, Vol. 23 Issue: 4 p521-531, 11p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.